Artykuły w czasopismach na temat „Disease progression score”
Utwórz poprawne odniesienie w stylach APA, MLA, Chicago, Harvard i wielu innych
Sprawdź 50 najlepszych artykułów w czasopismach naukowych na temat „Disease progression score”.
Przycisk „Dodaj do bibliografii” jest dostępny obok każdej pracy w bibliografii. Użyj go – a my automatycznie utworzymy odniesienie bibliograficzne do wybranej pracy w stylu cytowania, którego potrzebujesz: APA, MLA, Harvard, Chicago, Vancouver itp.
Możesz również pobrać pełny tekst publikacji naukowej w formacie „.pdf” i przeczytać adnotację do pracy online, jeśli odpowiednie parametry są dostępne w metadanych.
Przeglądaj artykuły w czasopismach z różnych dziedzin i twórz odpowiednie bibliografie.
Shan, Guogen, Xinlin Lu, Zhigang Li, Jessica Z. K. Caldwell, Charles Bernick i Jeffrey Cummings. "ADSS: A Composite Score to Detect Disease Progression in Alzheimer’s Disease". Journal of Alzheimer's Disease Reports 8, nr 1 (20.02.2024): 307–16. http://dx.doi.org/10.3233/adr-230043.
Pełny tekst źródłaRoussanov, Bisser V., Jeremy M. G. Taylor i Janis V. Giorgi. "Calculation and use of an HIV-1 disease progression score". AIDS 14, nr 17 (grudzień 2000): 2715–22. http://dx.doi.org/10.1097/00002030-200012010-00011.
Pełny tekst źródłaPihlstrøm, Lasse, Kristina Rebekka Morset, Espen Grimstad, Valeria Vitelli i Mathias Toft. "A cumulative genetic risk score predicts progression in Parkinson's disease". Movement Disorders 31, nr 4 (8.02.2016): 487–90. http://dx.doi.org/10.1002/mds.26505.
Pełny tekst źródłaUngaro, R., R. Jordan, C. Yzet, P. Bossuyt, F. Baert, T. Vanasek, G. R. D’Haens i in. "P240 CDEIS score of 2 is optimal cut-off associated with lower risk of disease progression in early Crohn’s disease: Data from the CALM study". Journal of Crohn's and Colitis 14, Supplement_1 (styczeń 2020): S264—S266. http://dx.doi.org/10.1093/ecco-jcc/jjz203.369.
Pełny tekst źródłaMoore, Ursula, Marni Jacobs, Meredith K. James, Anna G. Mayhew, Roberto Fernandez-Torron, Jia Feng, Avital Cnaan i in. "Assessment of disease progression in dysferlinopathy". Neurology 92, nr 5 (9.01.2019): e461-e474. http://dx.doi.org/10.1212/wnl.0000000000006858.
Pełny tekst źródłaShi, Manman, Yan Ouyang, Mingxin Yang, Meng Yang, Xiaoyan Zhang, Wei Huang, Weiming Wang i in. "IgA Nephropathy Susceptibility Loci and Disease Progression". Clinical Journal of the American Society of Nephrology 13, nr 9 (24.07.2018): 1330–38. http://dx.doi.org/10.2215/cjn.13701217.
Pełny tekst źródłaJönsson, Linus, Milana Ivkovic, Ron Handels, Anders Gustavsson, Teresa León, Julie Hviid Hahn-Pedersen i Lars Lau Raket. "OP142 Progression Analysis Versus Traditional Methods To Quantify Slowing Of Disease Progression In Alzheimer’s Disease". International Journal of Technology Assessment in Health Care 39, S1 (grudzień 2023): S42. http://dx.doi.org/10.1017/s0266462323001435.
Pełny tekst źródłaViticchi, Giovanna, Lorenzo Falsetti, Laura Buratti, Cristiano Boria, Simona Luzzi, Marco Bartolini, Leandro Provinciali i Mauro Silvestrini. "Framingham risk score can predict cognitive decline progression in Alzheimer's disease". Neurobiology of Aging 36, nr 11 (listopad 2015): 2940–45. http://dx.doi.org/10.1016/j.neurobiolaging.2015.07.023.
Pełny tekst źródłaRavindran, J., C. Cavill, C. Balakrishnan, S. M. Jones, E. Korendowych i N. J. McHugh. "A modified sharp score demonstrates disease progression in established psoriatic arthritis". Arthritis Care & Research 62, nr 1 (15.01.2010): 86–91. http://dx.doi.org/10.1002/acr.20018.
Pełny tekst źródłaKataoka, Hiroshi, i Kazuma Sugie. "Association between Fatigue and Hoehn-Yahr Staging in Parkinson’s Disease: Eight-Year Follow-Up Study". Neurology International 13, nr 2 (26.05.2021): 224–31. http://dx.doi.org/10.3390/neurolint13020023.
Pełny tekst źródłaPreziosa, Paolo, Elisabetta Pagani, Alessandro Meani, Lucia Moiola, Mariaemma Rodegher, Massimo Filippi i Maria A. Rocca. "Slowly Expanding Lesions Predict 9-Year Multiple Sclerosis Disease Progression". Neurology - Neuroimmunology Neuroinflammation 9, nr 2 (1.02.2022): e1139. http://dx.doi.org/10.1212/nxi.0000000000001139.
Pełny tekst źródłaWang, Linbo, Wei Cheng, Edmund T. Rolls, Fuli Dai, Weikang Gong, Jingnan Du, Wei Zhang i in. "Association of specific biotypes in patients with Parkinson disease and disease progression". Neurology 95, nr 11 (14.08.2020): e1445-e1460. http://dx.doi.org/10.1212/wnl.0000000000010498.
Pełny tekst źródłaSwanson, Gregory P., Steven Stone, Lauren Lenz i Todd Cohen. "Ability of cell-cycle progression score to predict risk for progression to metastatic disease and disease-specific mortality in prostate cancer patients after prostatectomy." Journal of Clinical Oncology 38, nr 15_suppl (20.05.2020): 5524. http://dx.doi.org/10.1200/jco.2020.38.15_suppl.5524.
Pełny tekst źródłaKoc, G. H., M. R. Kok, J. Luime, I. Tchetverikov, F. R. Kasiem, K. Wervers, Y. Goekoop-Ruiterman i in. "OP0065 THE DETERMINANTS OF RADIOGRAPHIC PROGRESSION IN EARLY PSA PATIENTS". Annals of the Rheumatic Diseases 82, Suppl 1 (30.05.2023): 44.2–45. http://dx.doi.org/10.1136/annrheumdis-2023-eular.5638.
Pełny tekst źródłaMarkusse, Iris M., Linda Dirven, Marianne van den Broek, Casper Bijkerk, K. Huub Han, H. Karel Ronday, Rebecca Bolce i in. "A Multibiomarker Disease Activity Score for Rheumatoid Arthritis Predicts Radiographic Joint Damage in the BeSt Study". Journal of Rheumatology 41, nr 11 (15.08.2014): 2114–19. http://dx.doi.org/10.3899/jrheum.131412.
Pełny tekst źródłaLipshitz, Jay, Sewanti Limaye i Dilip Patel. "Leukocyte Alkaline Phosphatase Score as a Marker of Severity and Progression of Myelodysplastic Syndrome." Blood 110, nr 11 (16.11.2007): 4625. http://dx.doi.org/10.1182/blood.v110.11.4625.4625.
Pełny tekst źródłaScelsi, Marzia A., Raiyan R. Khan, Marco Lorenzi, Leigh Christopher, Michael D. Greicius, Jonathan M. Schott, Sebastien Ourselin i Andre Altmann. "Genetic study of multimodal imaging Alzheimer’s disease progression score implicates novel loci". Brain 141, nr 7 (30.05.2018): 2167–80. http://dx.doi.org/10.1093/brain/awy141.
Pełny tekst źródłaEPSTEIN, JONATHAN I., CHARLES R. POUND, ALAN W. PARTIN i PATRICK C. WALSH. "DISEASE PROGRESSION FOLLOWING RADICAL PROSTATECTOMY IN MEN WITH GLEASON SCORE 7 TUMOR". Journal of Urology 160, nr 1 (lipiec 1998): 97–101. http://dx.doi.org/10.1016/s0022-5347(01)63045-3.
Pełny tekst źródłaRossetti, Heidi C., C. Munro Cullum, Linda S. Hynan i Laura H. Lacritz. "The CERAD Neuropsychologic Battery Total Score and the Progression of Alzheimer Disease". Alzheimer Disease & Associated Disorders 24, nr 2 (kwiecień 2010): 138–42. http://dx.doi.org/10.1097/wad.0b013e3181b76415.
Pełny tekst źródłaMigliorelli, Carolina, Meritxell Gómez-Martinez, Paula Subías-Beltrán, Mireia Claramunt-Molet, Sebastian Idelsohn-Zielonka, Eudald Mas-Hurtado, Felip Miralles, Marisol Montolio, Marina Roselló-Ruano i Julita Medina-Cantillo. "Multidimensional Biomechanics-Based Score to Assess Disease Progression in Duchenne Muscular Dystrophy". Sensors 23, nr 2 (11.01.2023): 831. http://dx.doi.org/10.3390/s23020831.
Pełny tekst źródłaBergamaschi, Roberto, Silvana Quaglini, Eleonora Tavazzi, Maria Pia Amato, Damiano Paolicelli, Valentina Zipoli, Alfredo Romani i in. "Immunomodulatory therapies delay disease progression in multiple sclerosis". Multiple Sclerosis Journal 22, nr 13 (20.07.2016): 1732–40. http://dx.doi.org/10.1177/1352458512445941.
Pełny tekst źródłaHam, Young Rok, Eu Jin Lee, Hae Ri Kim, Jae Wan Jeon, Ki Ryang Na, Kang Wook Lee i Dae Eun Choi. "Ultrasound Renal Score to Predict the Renal Disease Prognosis in Patients with Diabetic Kidney Disease: An Investigative Study". Diagnostics 13, nr 3 (31.01.2023): 515. http://dx.doi.org/10.3390/diagnostics13030515.
Pełny tekst źródłaJehn, Lutz B., Ulrich Costabel, Eda Boerner, Julia Wälscher, Dirk Theegarten, Christian Taube i Francesco Bonella. "Serum KL-6 as a Biomarker of Progression at Any Time in Fibrotic Interstitial Lung Disease". Journal of Clinical Medicine 12, nr 3 (1.02.2023): 1173. http://dx.doi.org/10.3390/jcm12031173.
Pełny tekst źródłaKang, Min Kyoung, Jung Hwan Shin, Tae Jung Kim, Ji Sung Lee, Byung-Woo Yoon i Sang-Bae Ko. "Use of proton pump inhibitor may be associated with progression of cerebral small vessel disease". PLOS ONE 17, nr 12 (21.12.2022): e0279257. http://dx.doi.org/10.1371/journal.pone.0279257.
Pełny tekst źródłaPavicic, Mirko, Kirk Overmyer, Attiq ur Rehman, Piet Jones, Daniel Jacobson i Kristiina Himanen. "Image-Based Methods to Score Fungal Pathogen Symptom Progression and Severity in Excised Arabidopsis Leaves". Plants 10, nr 1 (15.01.2021): 158. http://dx.doi.org/10.3390/plants10010158.
Pełny tekst źródłaChenniappan, Raghavi, Hanumanthappa Nandeesha, Shivanand Kattimani i Nandakumar Dalavaikodihalli Nanjaiah. "Interleukin-17 and Interleukin-10 Association with Disease Progression in Schizophrenia". Annals of Neurosciences 27, nr 1 (styczeń 2020): 24–28. http://dx.doi.org/10.1177/0972753120929565.
Pełny tekst źródłaSegala, Francesco Vladimiro, Emanuele Rando, Federica Salvati, Marcantonio Negri, Francesca Catania, Flavia Sanmartin, Rita Murri, Evangelos J. Giamarellos-Bourboulis i Massimo Fantoni. "Anakinra in hospitalized COVID-19 patients guided by baseline soluble urokinase plasminogen receptor plasma levels: A real world, retrospective cohort study". PLOS ONE 18, nr 4 (4.04.2023): e0273202. http://dx.doi.org/10.1371/journal.pone.0273202.
Pełny tekst źródłaUmemoto, George, Shinsuke Fujioka, Yasuyuki Iwasa, Yoshie Ozaki, Kayoko Koga, Kazumi Nishimura i Yoshio Tsuboi. "Impact of Progression of Parkinson’s Disease on Swallowing Ability and Oral Environment". Parkinson's Disease 2021 (23.04.2021): 1–6. http://dx.doi.org/10.1155/2021/5571556.
Pełny tekst źródłaXie, Linjun, Keke Hou, Huayan Xu, Hang Fu, Rong Xu, Hui Liu, Zhongqin Zhou, Zhenlin Li, Ming Yang i Yingkun Guo. "Chest CT features and progression of patients with coronavirus disease 2019". British Journal of Radiology 93, nr 1116 (1.12.2020): 20200219. http://dx.doi.org/10.1259/bjr.20200219.
Pełny tekst źródłaTsai, Tsung-Ying, Pai-Feng Hsu, Cheng-Hsueh Wu, Shao-Sung Huang, Wan-Leong Chan, Shing-Jong Lin, Jaw-Wen Chen, Tse-Min Lu i Hsin-Bang Leu. "Association between Coronary Artery Plaque Progression and Liver Fibrosis Biomarkers in Population with Low Calcium Scores". Nutrients 14, nr 15 (30.07.2022): 3163. http://dx.doi.org/10.3390/nu14153163.
Pełny tekst źródłaChen, Szu-Ju, Yu-Chiao Chi, Chang-Han Ho, Wei-Shiung Yang i Chin-Hsien Lin. "Plasma Lipopolysaccharide-Binding Protein Reflects Risk and Progression of Parkinson’s Disease". Journal of Parkinson's Disease 11, nr 3 (2.08.2021): 1129–39. http://dx.doi.org/10.3233/jpd-212574.
Pełny tekst źródłaJedynak, Bruno M., Andrew Lang, Bo Liu, Elyse Katz, Yanwei Zhang, Bradley T. Wyman, David Raunig, C. Pierre Jedynak, Brian Caffo i Jerry L. Prince. "A computational neurodegenerative disease progression score: Method and results with the Alzheimer's disease neuroimaging initiative cohort". NeuroImage 63, nr 3 (listopad 2012): 1478–86. http://dx.doi.org/10.1016/j.neuroimage.2012.07.059.
Pełny tekst źródłaYavuz, Yasemin. "Are the Beck depression inventory score, SF 36 score and progression of the disease changing with education in chronic kidney disease patients?" Annals of Medical Research 25, nr 4 (2018): 723. http://dx.doi.org/10.5455/annalsmedres.2018.05.091.
Pełny tekst źródłaYang, Yongbo, Jian Wang, Qun Liang, Yi Wang, Xinhua Chen, Qingrong Zhang, Shijie Na i in. "PHACTR1 is associated with disease progression in Chinese Moyamoya disease". PeerJ 8 (5.05.2020): e8841. http://dx.doi.org/10.7717/peerj.8841.
Pełny tekst źródłaOefelein, Michael G. "RE: DISEASE PROGRESSION FOLLOWING RADICAL PROSTATECTOMY IN MEN WITH GLEASON SCORE 7 TUMOR". Journal of Urology 161, nr 1 (styczeń 1999): 231. http://dx.doi.org/10.1016/s0022-5347(01)62114-1.
Pełny tekst źródłaSerednicka, K., A. E. Smyth, C. M. Black i C. P. Denton. "Using a self-reported functional score to assess disease progression in systemic sclerosis". Rheumatology 46, nr 7 (9.05.2007): 1107–10. http://dx.doi.org/10.1093/rheumatology/kel432.
Pełny tekst źródłaHarrison, Madaline B., Scott A. Wylie, Robert C. Frysinger, James T. Patrie, Diane S. Huss, Lillian J. Currie i G. Frederick Wooten. "UPDRS activity of daily living score as a marker of Parkinson's disease progression". Movement Disorders 24, nr 2 (30.01.2009): 224–30. http://dx.doi.org/10.1002/mds.22335.
Pełny tekst źródłaRodríguez-Rodríguez, E., P. Sánchez-Juan, J. L. Vázquez-Higuera, I. Mateo, A. Pozueta, J. Berciano, S. Cervantes i in. "Genetic risk score predicting accelerated progression from mild cognitive impairment to Alzheimer’s disease". Journal of Neural Transmission 120, nr 5 (20.11.2012): 807–12. http://dx.doi.org/10.1007/s00702-012-0920-x.
Pełny tekst źródłaGao, Yang, Hong-Liang Zhang, Meiying Xin, Dong Wang, Nannan Zheng, Shuang Wang, Jiancheng Xu, Ying Wang, Jie Zhu i Jiachun Feng. "Serum Folate Correlates with Severity of Guillain-Barré Syndrome and Predicts Disease Progression". BioMed Research International 2018 (14.06.2018): 1–5. http://dx.doi.org/10.1155/2018/5703279.
Pełny tekst źródłaRossi, Silvia, Fabio Buttari, Valeria Studer, Caterina Motta, Paolo Gravina, Maura Castelli, Vilma Mantovani i in. "The (AAT)n repeat of the cannabinoid CB1 receptor gene influences disease progression in relapsing multiple sclerosis". Multiple Sclerosis Journal 17, nr 3 (8.12.2010): 281–88. http://dx.doi.org/10.1177/1352458510388680.
Pełny tekst źródłaHasimoglu, Yasemin G., Xiqun Chen, Rachit Bakshi, Michael A. Schwarzschild i Eric A. Macklin. "Does Serum Urate Change as Parkinson’s Disease Progresses?" Journal of Parkinson's Disease 10, nr 4 (27.10.2020): 1571–76. http://dx.doi.org/10.3233/jpd-202064.
Pełny tekst źródłaStopsack, Konrad H., Charles A. Whittaker, Travis A. Gerke, Massimo Loda, Philip W. Kantoff, Lorelei A. Mucci i Angelika Amon. "Aneuploidy drives lethal progression in prostate cancer". Proceedings of the National Academy of Sciences 116, nr 23 (13.05.2019): 11390–95. http://dx.doi.org/10.1073/pnas.1902645116.
Pełny tekst źródłaSharad, Shashwat, Zsã³fia Sztupinszki, Zoltan Szallasi, Inger L. Rosner, Shiv Srivastava, Albert Dobi, Jennifer Cullen i Hua Li. "PMEPA1 gene isoforms to indicate disease progression in solid tumors." Journal of Clinical Oncology 37, nr 15_suppl (20.05.2019): e16580-e16580. http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e16580.
Pełny tekst źródłaKister, Ilya, i Orhun H. Kantarci. "Multiple Sclerosis Severity Score: Concept and applications". Multiple Sclerosis Journal 26, nr 5 (22.01.2020): 548–53. http://dx.doi.org/10.1177/1352458519880125.
Pełny tekst źródłaGautam, Sachin, Rahul Kumar, Dharam Pal Bhadoria, Govind Mawari, Naresh Kumar, Mradul K. Daga, Sanjay Pandit i in. "Clinical profile of hospitalised moderate category COVID-19 patients: Short study from a Tertiary Care Centre in Delhi". Journal of Family Medicine and Primary Care 12, nr 8 (sierpień 2023): 1644–53. http://dx.doi.org/10.4103/jfmpc.jfmpc_2245_22.
Pełny tekst źródłaMills, James A., Jeffrey D. Long, Amrita Mohan, Jennifer J. Ware i Cristina Sampaio. "Cognitive and Motor Norms for Huntington’s Disease". Archives of Clinical Neuropsychology 35, nr 6 (14.05.2020): 671–82. http://dx.doi.org/10.1093/arclin/acaa026.
Pełny tekst źródłaBrandt, L., H. Schulze-Koops, T. Hügle, M. J. Nissen, H. Paul i R. Muller. "OP0185 RADIOGRAPHIC PROGRESSION DESPITE PERSISTENT LDA OR REMISSION IS INFLUENCED BY CURRENT SMOKING RATHER THAN THE RESPECTIVE DAS 28 LEVEL, RESULTS OF THE SWISS RHEUMATOID ARTHRITIS REGISTER (SCQM)". Annals of the Rheumatic Diseases 80, Suppl 1 (19.05.2021): 112.1–112. http://dx.doi.org/10.1136/annrheumdis-2021-eular.2557.
Pełny tekst źródłaClancy, Una, Stephen D. J. Makin, Caroline A. McHutchison, Vera Cvoro, Francesca M. Chappell, Maria del C. Valdés Hernández, Eleni Sakka, Fergus Doubal i Joanna M. Wardlaw. "Impact of Small Vessel Disease Progression on Long-term Cognitive and Functional Changes After Stroke". Neurology 98, nr 14 (7.02.2022): e1459-e1469. http://dx.doi.org/10.1212/wnl.0000000000200005.
Pełny tekst źródłaMello, Ricardo Andrade Fernandes de, Melissa Bosi Nonato Mello, Laís Bastos Pessanha i Ana Paula Alves Fonseca. "Skeletal involvement in Gaucher disease: extent of bone disease, splenic volume, and quality of life". Radiologia Brasileira 54, nr 2 (kwiecień 2021): 71–76. http://dx.doi.org/10.1590/0100-3984.2020.0014.
Pełny tekst źródłaJedynak, Bruno, Zhou Ye, Andrew Lang, Runze Tang, Pierre Jedynak i Jerry Prince. "P1-197: The Alzheimer's Disease Progression Score (ADPS) can predict the transition from MCI to Alzheimer's disease". Alzheimer's & Dementia 9 (lipiec 2013): P223. http://dx.doi.org/10.1016/j.jalz.2013.05.420.
Pełny tekst źródła